The Treat and Reduce Obesity Act (TROA) could be headed for a markup before August in the House Ways & Means Committee, as the Congressional Budget Office reviews the possible cost savings the bill could bring in a longer time frame if GLP-1 drugs for obesity were covered by Medicare. “We're hearing talk of a markup on innovation in Ways and Means, maybe before August, where (TROA) could be on that docket,” Joel White, president of the Council for Affordable...